Pain and the Placebo/Nocebo Effect




Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997). Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 71, 135–140.PubMed


Benedetti, F., Amanzio, M., Baldi, S., Casadio, C., & Maggi, G. (1999). Inducing placebo respiratory depressant responses in humans via opioid receptors. European Journal of Neuroscience, 11, 625–631.PubMed


Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003). Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. Journal of Neuroscience, 23, 4315–4323.PubMed


Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., et al. (2006a). Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain, 121, 133–144.PubMed


Benedetti, F., Amanzio, M., Vighetti, S., Asteggiano, G. (2006b). The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. Journal of Neuroscience, 26, 12014–12022.PubMed


Benedetti, F., Lanotte, M., Lopiano, L., Colloca, L. (2007). When words are painful: Unraveling the mechanisms of the nocebo effect. Neuroscience, 147, 260–271.PubMed


Benedetti, F., Carlino, E., & Pollo, A. (2011a). How placebos change the patient’s brain. Neuropsychopharmacology, 36, 339–354. doi:10.1038/npp 2010.81.PubMed


Benedetti, F., Amanzio, M., & Thoen, W. (2011b). Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology, 213, 791–797. doi:10.​1007/​s00213-010-2037-y.PubMed


Bingel, U., Lorenz, J., Schoell, E., Weiller, C., & Büchel, C. (2006). Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain, 120, 8–15.PubMed


Charron, J., Rainville, P., & Marchand, S. (2006). Direct comparison of placebo effects on clinical and experimental pain. The Clinical Journal of Pain, 22, 204–211.PubMed


Chua, P., Krams, M., Toni, I., Passingham, R. & Dolan, R. (1999). A functional anatomy of anticipatory anxiety. NeuroImage, 9, 563–571.PubMed


Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: Is mind as real as matter? Nature Reviews. Neuroscience, 6, 545–552.PubMed


Colloca, L., & Benedetti, F. (2006). How prior experience shapes placebo analgesia. Pain, 124, 126–133.PubMed


Colloca, L., & Benedetti, F. (2007). Nocebo hyperalgesia: How anxiety is turned into pain. Current Opinion in Anaesthesiology, 20, 435–439.PubMed


Colloca, L., & Benedetti, F. (2009). Placebo analgesia induced by social observational learning. Pain, 144, 28–34.PubMed


Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004). Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurology, 3, 679–684.PubMed


Colloca, L., Benedetti, F., & Porro, C. A. (2008a). Experimental designs and brain mapping approaches for studying the placebo analgesic effect. European Journal of Applied Physiology, 102, 371–380.PubMed


Colloca, L., Sigaudo, M., & Benedetti, F. (2008b). The role of learning in nocebo and placebo effects. Pain, 136, 211–218.PubMed


Colloca, L., Tinazzi, M., Recchia, S., Le Pera, D., Fiaschi, A., Benedetti, F., et al. (2009). Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain, 139, 306–314.PubMed


de la Fuente-Fernández, R. (2010). The placebo-reward hypothesis: Dopamine and the placebo effect. Parkinsonism & Related Disorders, 15(S3), S72–S74.


de la Fuente-Fernández, R., & Stoessl, A. J. (2002). The placebo effect in Parkinson’s disease. Trends in Neurosciences, 6, 302–306.


de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001). Expectation and dopamine release: Mechanism of the placebo effect in Parkinson’s disease. Science, 293, 1164–1166.PubMed


de la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J. et al. (2002). Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research, 136, 359–363.PubMed


Eippert, F., Finsterbusch, J., Bingel, U., & Büchel, C. (2009a). Direct evidence for spinal cord involvement in placebo analgesia. Science, 326, 404.PubMed


Eippert, F., Bingel, U., Schoell, E. D., Yacubian, J., Klinger, R., Lorenz, J., et al. (2009b). Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron, 63, 533–543.PubMed


Enck, P., Benedetti, F., & Schedlowski, M. (2008). New insights into the placebo and nocebo responses. Neuron, 59, 195–206.PubMed


Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. The Journal of Neuropsychiatry and Clinical Neurosciences, 8, 194–201.PubMed


Goebel, M. U., Trebst, A. E., Steiner, J., Xie, Y. F., Exton, M. S., Frede, S., et al. (2002). Behavioral conditioning of immunosuppression is possible in humans. The FASEB Journal, 16, 1869–1873.


Goffaux, P., Redmond, W. J., Rainville, P., & Marchand, S. (2007). Descending analgesia – When the spine echoes what the brain expects. Pain, 130, 137–143.PubMed


Gospic, K., Gunnarsson, T., Fransson, P., Ingvar, M., Lindefors, N., & Petrovic, P. (2008). Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology, 197, 295–307.PubMed


Gracely, R. H., Dubner, R., Wolskee, P. J., & Deeter, W. R. (1983). Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature, 306, 264–265.PubMed


Gracely, R. H., Dubner, R., Deeter, W. D., & Wolskee, P. J. (1985). Clinician’s expectations influence placebo analgesia. The Lancet, 5, 43.

Oct 16, 2016 | Posted by in PAIN MEDICINE | Comments Off on Pain and the Placebo/Nocebo Effect

Full access? Get Clinical Tree

Get Clinical Tree app for offline access